Form 8-K - Current report:
SEC Accession No. 0001193125-20-211918
Filing Date
2020-08-06
Accepted
2020-08-06 16:16:29
Documents
12
Period of Report
2020-08-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d743739d8k.htm   iXBRL 8-K 25017
  Complete submission text file 0001193125-20-211918.txt   151281

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA teva-20200804.xsd EX-101.SCH 3072
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20200804_lab.xml EX-101.LAB 18839
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20200804_pre.xml EX-101.PRE 11840
5 EXTRACTED XBRL INSTANCE DOCUMENT d743739d8k_htm.xml XML 3765
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-16174 | Film No.: 201081870
SIC: 2834 Pharmaceutical Preparations